Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 8,750.00
+70.00 (0.81%)
Oct 29, 2026, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 628.95 billion as of October 28, 2026. It is the 14,976th most valuable company in the world and the 393rd biggest in South Korea. Its market cap has increased by 40.86% in one year.
Market Cap
628.95B
Enterprise Value
645.40B
Revenue
53.02B
Global Rank
Country Rank
#393 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 628.95B, an increase of 567.24%. That is a compound annual growth rate of 7.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 628.95B | 24.07% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 656.77B |
| Pharmicell | 576.04B |
| Hyundai Bioscience | 573.23B |
| Onconic Therapeutics | 560.79B |
| Proteina | 514.24B |
| GI Innovation | 494.19B |
| Medy-Tox | 427.54B |
| AbClon | 425.98B |